🇺🇸 FDA
Patent

US 10344064

Engineered potent cytotoxic stapled BH3 peptides

granted A61KA61K31/635A61K38/00

Quick answer

US patent 10344064 (Engineered potent cytotoxic stapled BH3 peptides) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/635, A61K38/00, A61K38/10, A61K38/12